The Harvey J. Cohen, MD, PhD Endowed Lectureship in Pediatrics
Predicting Patient Outcomes from Single Cells in Childhood Cancer
Kara Davis, DO
Assistant Professor, Pediatric Hematology/Oncology
Stanford School of Medicine
Acute lymphoblastic leukemia (ALL) is the most common cancer of childhood and one of the most deadly despite impressive improvements in survival. The Davis lab uses single-cell, high-dimensional analysis to identify the most important cells, those that are resistant to standard and cutting-edge therapies, leading to relapse. By identifying and understanding these treatment resistant cells can we work to prevent relapse and cure more children and young adults with ALL.